The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol

The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol

BackgroundThe basal follicle stimulating hormone (FSH)/luteinizing hormone (LH) ratio is a useful predictor of ovarian response. In this study, we investigated whether the FSH/LH ratios during the entire controlled ovarian stimulation (COS) can be used as effective predictors of outcomes in women un...

Full description

Bibliographic Details
Main Authors:	Shen Zhao, Huihui Xu, Xian Wu, Lan Xia, Jian Li, Dan Zhang, Aijun Zhang, Bufang Xu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Endocrinology
Subjects:	embryological outcomes GnRH antagonist (GnRH-ant) protocol ovarian response reproductive potential FSH & LH
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1093954/full

Similar Items

The enigma of the gonadotropin-releasing hormone pulse frequency governing individual secretion of luteinizing hormone and follicle-stimulating hormone
by: Cornelis B. Lambalk, M.D., Ph.D.
Published: (2023-06-01)

Flexible Low-Dose GnRH Antagonist Protocol Is Effective in Patients With Sufficient Ovarian Reserve in IVF
by: Dan Zhang, et al.
Published: (2018-12-01)

GnRH Antagonist Protocol With Cessation of Cetrorelix on Trigger Day Improves Embryological Outcomes for Patients With Sufficient Ovarian Reserve
by: Huihui Xu, et al.
Published: (2021-10-01)

Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial
by: Yun Wang, et al.
Published: (2018-08-01)

GnRH agonist versus GnRH antagonist in <it>in vitro</it> fertilization and embryo transfer (IVF/ET)
by: Depalo Raffaella, et al.
Published: (2012-04-01)

Early administration of gonadotropin-releasing hormone antagonist versus flexible antagonist ovarian stimulation protocol in poor responders: a randomized clinical trial
by: Tayebeh Esfidani, et al.
Published: (2021-10-01)

Recent Development of Non-Peptide GnRH Antagonists
by: Feng-Ling Tukun, et al.
Published: (2017-12-01)

LH level on trigger day, number of follicles ≥16 mm but <18 mm, and number of retrieved oocytes are independent risk factors for polyspermy in gonadotropin-releasing hormone antagonist protocol
by: Qiongyu Wu, et al.
Published: (2024-12-01)

Neurobiological study of fish brains gives insights into the nature of Gonadotropin-releasing hormone 1-3 neurons.
by: Tomomi eKarigo, et al.
Published: (2013-11-01)

Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix
by: Kristof Chwalisz, M.D., Ph.D.
Published: (2023-06-01)

GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran
by: Ensieh Tehraninejad, et al.
Published: (2011-01-01)

Editorial: Gonadotropin-Releasing Hormone Receptor Signaling and Functions
by: Ivana Bjelobaba, et al.
Published: (2018-04-01)

Intraindividual Embryo Morphokinetics Are Not Affected by a Switch of the Ovarian Stimulation Protocol Between GnRH Agonist vs. Antagonist Regimens in Consecutive Cycles
by: Jens E. Dietrich, et al.
Published: (2020-04-01)

GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis
by: M.A.F. Youssef, et al.
Published: (2015-05-01)

Clinical applications of gonadotropin-releasing hormone analogues: a broad impact on reproductive medicine
by: Farrah L. Saleh, M.D., et al.
Published: (2023-06-01)

GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile
by: Nirja Chaudhari, et al.
Published: (2018-04-01)

Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study
by: Shan Liu, et al.
Published: (2021-07-01)

Pulsatile gonadotropin-releasing hormone: clinical applications of a physiologic paradigmEssential Points
by: Marco Filicori, M.D.
Published: (2023-06-01)

Use of gonadotropin-releasing hormone (GnRH) agonist trigger in fertility preservation for patients with inherited genetic disorders
by: Jamie Merkison, et al.
Published: (2022-09-01)

A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
by: Yoshiyuki Miyazawa, et al.
Published: (2017-08-01)

Ganirelix and the prevention of premature luteinizing hormone surges
by: Bernadette Mannaerts, Ph.D.
Published: (2023-06-01)

A novel GnRH antagonist protocol based on LH levels versus traditional flexible GnRH antagonist protocol in PCOS patients undergoing in vitro fertilization: study protocol for a randomized controlled, non-inferiority trial
by: Shan Liu, et al.
Published: (2022-08-01)

Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs
by: Maira Huerta-Reyes, et al.
Published: (2019-10-01)

Economic evaluation of highly purified human menotropin or recombinant follicle-stimulating hormone for controlled ovarian stimulation in high-responder patients: analysis of the Menopur in Gonadotropin-releasing Hormone Antagonist Single Embryo Transfer–High Responder (MEGASET-HR) trial
by: Jared C. Robins, M.D., et al.
Published: (2020-12-01)

Female reproductive functions of the neuropeptide PACAP
by: Miklos Koppan, et al.
Published: (2022-09-01)

GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial
by: Francesco M. Fusi, et al.
Published: (2019-11-01)

Protocol shift from agonist to antagonist or vice versa after an unsuccessful intracytoplasmic sperm injection cycle on the same patient does not improve outcome
by: Yavuz Emre Şükür, et al.
Published: (2018-06-01)

Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis
by: Liting Zhang, et al.
Published: (2022-12-01)

Comparison of the Effects of Gonadotropin Releasing Hormone Agonists and Antagonists on Endometrial Development in Women who Had Inadequate Endometrial Development in a Previous Assisted Reproduction Treatment Cycle; A Randomised Parallel Group Pilot Trial
by: Özkan Aydın Leylek, et al.
Published: (2008-12-01)

Rapid reduction of adenomyosis coexisting with leiomyoma volume during treatment with Relugolix
by: Keitaro Yamanaka, et al.
Published: (2023-12-01)

Fixed versus Flexible Gonadotropin Releasing Hormone Antagonist Protocol in Controlled Ovarian Stimulation for Invitro Fertilization in Women with Polycystic Ovary Syndrome
by: Batool Hossein Rashidi, et al.
Published: (2015-10-01)

Down-regulation of S100P induces apoptosis in endometrial epithelial cell during GnRH antagonist protocol
by: Dan Zhang, et al.
Published: (2021-07-01)

Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF
by: Andrea Roberto Carosso, et al.
Published: (2021-03-01)

Ovarian sensitivity index affects clinical pregnancy and live birth rates in gonadotropin-releasing hormone agonist and antagonist in vitro fertilization cycles
by: Chao Chin Hsu, et al.
Published: (2024-12-01)

Comparison of pregnancy outcome after fresh embryo transfer between GnRH antagonist and GnRH agonist regimens in patients with thin endometrium
by: Depeng Zhao, et al.
Published: (2023-01-01)

Administración de pulsos de gnrh a cerdas lactantes y su efecto sobre el estro y la ovulación
by: José Luis Ramírez, et al.
Published: (2010-06-01)

Lower FSH With Normal Fertility in Male Mice Lacking Gonadotroph Kisspeptin Receptor
by: Yaping Ma, et al.
Published: (2022-04-01)

Comparison of Controlled Ovarian Stimulation Protocols on IVF Outcome in Normal and Poor Responders
by: Deniz Esinler, et al.
Published: (2013-12-01)

Coasting Versus GnRH Antagonist Salvage for the Prevention of Ovarian Hyperstimulation Syndrome
by: Cavidan Gülerman, et al.
Published: (2013-12-01)

A role for glial fibrillary acidic protein (GFAP)-expressing cells in the regulation of gonadotropin-releasing hormone (GnRH) but not arcuate kisspeptin neuron output in male mice
by: Charlotte Vanacker, et al.
Published: (2021-07-01)